Did you know that Purdue's biggest legal stand about their medicines, “less than 1% addiction claim", actually came from a 5-sentence letter in a 1980 issue of The New England Journal of Medicine?

Purdue Pharma wasn’t just another greedy pharma giant. It was, for many years, a wildly successful hyper-growth company. The kind of revenue most founders, could only dream of, and yet it blew up spectacularly.
​

Let's unpack on how hubris, product risk blindness, and moral shortcuts can sink even the most promising business.

Purdue Pharma started in 1892, founded by two New York physicians as The Purdue Frederick Company, but it came into limelight In 1952, when the Sackler brothers, Arthur, Mortimer, and Raymond, bought the company.

​
At first, Purdue sold pedestrian pharma products — laxatives, earwax removers, and antiseptics. Nothing fancy. But Arthur Sackler had a different plan, he wasn’t just a doctor, he was a marketing genius, coming high on the back of his direct-to-physician advertising success for Valium (yes, that Valium).

Game Changer for Purdue, When they found Success in "Pain"

In 1996, Purdue launched OxyContin, a slow-release formulation of oxycodone.
​
​The pitch?

"Finally, a powerful opioid that isn’t addictive."

• Extended-release mechanism would prevent abuse.
• Sales reps were trained to say the addiction risk was less than 1%
• Doctors loved it. Chronic pain was finally “manageable.” And patients? They felt better, until ofcourse, they didn’t.
• Within 4 years, OxyContin was a billion-dollar drug.

Did you know that interestingly, before focusing on pain management, Purdue sold products like earwax removers and laxatives?

Unprecedented Growth:

• They expanded their sales force from 318 reps to 671 within 5 years.
• Sponsored 20,000+ educational pain seminars.
• Pumped millions into physician incentives, "thought leader" panels, and medical journals.
• They weren’t selling a drug; it was a cultural shift.

But, Purdue crossed a line when it tied its entire business to denial.

The real moment of collapse started happening when Every board meeting, sales meeting, and investor conversation revolved around one assumption, that they can't be held responsible for addiction.

Even as OxyContin pills hit black markets, were crushed, snorted, and injected, Purdue insisted it was patient misuse, not a product flaw.

The FDA started circling, The media started digging and by 2007, the first federal charges hit, but Purdue paid $634.5 million in fines for misbranding,Yet, sales barely slowed.
​

Did you know that McKinsey advised Purdue on how to push OxyContin sales, leading to $600M+ in McKinsey’s own settlements?

Triggers for Slowdown:

• In 2010, Purdue reformulates OxyContin to make it harder to abuse.
  ​
• But by then, the damage was systemic, addicted patients had already shifted to heroin and fentanyl.
  ​
• Too little, Too Late, with 500,000+ lives lost, Lawsuits exploded; States, counties, cities, hospitals, tribes, everyone filed claims.
  ​
• By 2019, Purdue filed for Chapter 11 bankruptcy with liabilities exceeding $10 billion.
  ​
• In 2024-25, the final bankruptcy plan pushed Sacklers, to contribute up to $6.5 billion in settlement funds.

5 Lessons to learn from $35 Billion hole in Purdue's Legacy:

1. Product risk compounds, if left Unchecked: Purdue scaled faster than it understood the full consequences of its product.
   ​Takeaway: Your product might work but still create unintended harm at scale.
   ​
2. Marketing cannot override everything: Purdue sold a narrative not backed by proper clinical data.
   ​Takeaway: The Job of a Founder is to verify the products with market reality and not just look for excuses through marketing.
   ​
3. Don't Ignore Feedback: Sales-driven culture without internal dissent is dangerous, Purdue Reps who questioned addiction risks, were often sidelined.​
   Takeaway: Create feedback loops where your own team can flag risk early.
   ​
4. Cash can't cure Ethics: Your revenue isn’t a cushion against ethical collapse, Purdue made billions, but no amount of capital could offset reputational ruin.
   ​Takeaway: No matter what you think about capitalism, Brand trust takes decades to build and days to lose.​
   ​
5. Don't ignore Early Risks: Crisis delayed is crisis multiplied, Purdue denied, delayed, and deflected for over a decade and its crisis multiplied by Billions of Dollars.
   ​Takeaway: The longer you avoid systemic problems, the bigger time bomb you are eventually waiting for to explode.